Navigation Links
Mattresses do Play a Role in Low Back Pain

If you have lower back pain, the right mattress can make a difference. //Three-quarters of physicians say your best bet is a firm bed mattress, but a new study says they could be wrong. The new research finds medium-firm mattresses are more effective at relieving back pain.

Physicians often get frustrated when patients ask them what type of bed is best for their lower back pain. Few studies have been done on this issue to support their answers. Therefore, researchers in Spain conducted a study to test the effectiveness of a firm vs. a medium-firm mattress when it comes to lower back pain.

The study included 313 people who had their own bed mattresses replaced with either a firm or a medium-firm mattress. The participants did not know what type of mattress they were given. The individuals reported the degree of low back pain experienced while lying in bed, and after waking up in the morning as well as their degree of disability before and three months after the start of the study.

Study authors say the people who used the medium-firm mattress had more of their back pain symptoms alleviated. Specifically, those who slept on a medium-firm mattress were twice as likely to report improvements in low back pain while lying in bed, when getting out of bed and in disability associated with back pain. The participants who used the medium-firm mattresses also reported a decrease in the need for pain killing drugs.

Researchers say, their findings stress that recommendations for daily living, such as what kind of mattress to use, may have a relevant effect on the clinical course of low-back pain.


'"/>




Page: 1

Related medicine news :

1. Green tea beneficial in preventing osteoarthritis
2. Eating Greens fights cancer
3. Green Tea Might Help Patients With Prostate Cancer
4. Yet Another Use For Green Tea Extract
5. Exposure To Greenery And Graffiti May Affect Obesity
6. Green Beans for Cancer Prevention and Treatment.
7. Can Green Tea Prevent Alzheimers?
8. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
9. Polyphenols in Green Tea Cause Liver Damage At High Doses
10. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
11. Green Light From EU To Poultry Farmers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mattresses Play Role Low Back Pain

(Date:5/9/2008)... 9 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: AD...lty pharmaceutical company,with operations in Chin...ceutical Inc., today announced that its consolidat...r 31, 2007, which were included in its,Annual Repo...ange,Commission on April 14, 2008, contained a ,go...
(Date:5/9/2008)... grain may provide protection against heart diseas...RLINGTON, Va., May 8 /PRNewswire/ -- Brown rice, a...d ranks of healthful whole grains, according,to an...g Administration,(FDA) that will allow brown rice ...This will enable consumers to easily identify brow...
(Date:5/9/2008)...f., May 9 /PRNewswire-USNewsire/ -- U.S.,corporati...elp victims of,the Cyclone Nargis in Myanmar are r... International, to ensure that the aid will reach ...It,s important to remember the complete story of t...with the people and organizations that,provide the...
(Date:5/9/2008)...RNewswire/ -- Summary: With the recent devastating...eaths and leaving over a,million people homeless, ...preneurs Sharon Tucci and Steve Jones have launche...ard awareness for humanitarian needs,with hopes o... initial goal,of having 1,000 individuals and comp...
Breaking Medicine News(10 mins):Health News:AMDL Reports Going Concern Qualification 2Health News:FDA Approves Health Claim for Brown Rice 2Health News:FDA Approves Health Claim for Brown Rice 3Health News:FDA Approves Health Claim for Brown Rice 4Health News:FDA Approves Health Claim for Brown Rice 5Health News:Direct Relief's Corporate Partners Key to Aiding Cyclone Victims 2Health News:New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals 2
...on an earlier discovery that a gene called IRF6 is... palate, researchers at the University of Iowa Roy...d their colleagues have identified the function of...e Oct. 15 in Nature Genetics, reveal an unexpected...
... of home care for several thousands of elderly peo...ectors.// According to the Commission for Social ...re givers too rushed, giving insufficient time to ...giving 15 minute slots of help, before moving on t...
...t government-sponsored reports released on Tuesday... in spite of the risks due to contamination. These.... "Overall, for major health outcomes among adult... outweigh the risks. Somehow, this evidence has be...
...accine has proved to be efficient on animals accor...ntario.// "Perhaps we can cure HIV infection. Th...sity of Western Ontario. Clinical trials of the va...i million to be invested by Curocom Co., a compan...
Other Medicine News:Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 2Health News:Gene Involved In Common Birth Defect Also Regulates Skin Biology 3Health News:Standards of Home Care for Elderly Needs Change 2Health News:Eating Fish has more Benefits than Risks 2
(Date:5/7/2008)... Study to Evaluate Preferred Induction Dosing R...Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) toda...s, a,division of Wyeth (NYSE: WYE ), has commence...al of TRU-015 in patients with rheumatoid arthriti...aceuticals is developing,TRU-015, SBI-087 and othe...
(Date:5/7/2008)...INGTON, May 7 /- Shire plc ...opharmaceutical company, today,announced findings ...mine,treatment differences with DAYTRANA(TM) (meth...irls aged 6 to 12 years with Attention Deficit,Hyp...analysis reaffirmed,that DAYTRANA has an establish...
(Date:5/7/2008)...INGTON, May 7 /- Shire plc ...opharmaceutical company, presented,today at a majo...otal trial,results of INTUNIV, a selective alpha-2...e-daily medication, which is being evaluated for t...Hyperactivity Disorder,(ADHD). The data demonstrat...
(Date:5/7/2008)...BRUNSWICK, N.J., May 7 /- J...st for financial analysts on Friday, May 9,at 4:00... Pain Society,s,(APS) annual meeting in Tampa, Fla...tional tapentadol immediate release (IR), a novel ... for the first time at APS., A pre-recorded Webca...
Breaking Medicine Technology:Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 2Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 3Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6Mitchell Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research 3B Mitchell Endorses Ground Breaking Traumatic Brain Inj 823 1Mitchell Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research 3B Mitchell Endorses Ground Breaking Traumatic Brain Inj 823 2Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference 6020 1Novant Health Completes Purchase of MedQuest 6015 1Novant Health Completes Purchase of MedQuest 6015 2Novant Health Completes Purchase of MedQuest 6015 3HIV drug resistance risk in mothers reduced by combination of common drugs 6010 1HIV drug resistance risk in mothers reduced by combination of common drugs 6010 2
...Hematology and Oncology CHU Lapeyronie, Montpellie...se protein that has long been recognized as a mark...omplement a range of diagnostic markers to monitor...omic rationalization becomes a necessity throughou... areas of frequent laboratory testing may need car...
...Editor , Some form of electronic hematology ...aboratories. A blood cell count is usually the fir...ule out anemia or infection, and monitor cancer pa...fficult to imagine medical care without this workh...,, Early testing of sonar, developed to detect ...
Other Medicine Technology:Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 2Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 3Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing 4Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 2Hematology Analyzers Simple, Sophisticated Technology Serving All Patients 3
Angled shafts with 11 mm long tips. Jaws have longitudinal meshing serrations. Slide lock and serrated handle with polished finish.
Multi-curved shafts with straight blades and longitudinal serrations. Slide lock and serrated handle with polished finish. Blade length: 27 mm.
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish.
Smooth pointed tips open to 3.0 mm. 45 degree cross action angled shafts. Tip to Angle Length: 12.0 mm. Round handle.
Medicine Products: